Upgrade to SI Premium - Free Trial

FibroGen (FGEN) PT Raised to $72 at Mizuho Securities on Strong Ph3 MACE Data

November 11, 2019 7:08 AM
Mizuho Securities analyst Difei Yang raised the price target on FibroGen (NASDAQ: FGEN) to $72.00 (from $65.00) after the company ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change

Next Articles